Recent comprehensive genomic analyses of small-cell lung cancer (SCLC) have revealed a substantial mutational burden along with significant chromosomal rearrangements, typically involving the loss of TP53 and RB1 in addition to MYC oncogene amplification [9,11,13,14,15]. The gene discussed is TP53; the disease is small cell lung carcinoma.